(CTAS) Cintas - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1729081059
Stock: Uniforms, Rental, Safety, Cleaning
Total Rating 45
Risk 91
Buy Signal -1.05
| Risk 5d forecast | |
|---|---|
| Volatility | 21.6% |
| Relative Tail Risk | -5.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.42 |
| Alpha | -17.34 |
| Character TTM | |
|---|---|
| Beta | 0.449 |
| Beta Downside | 0.373 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.69% |
| CAGR/Max DD | 0.93 |
EPS (Earnings per Share)
Revenue
Description: CTAS Cintas March 04, 2026
Cintas Corporation (CTAS) provides corporate identity uniforms and related business services. The company operates in the Uniform Rental and Facility Services, First Aid and Safety Services, and All Other segments.
Cintass business model relies on recurring revenue from uniform rental and facility services. These services include flame-resistant clothing, mat and mop rental, and restroom cleaning. The uniform rental industry often involves long-term contracts, providing stable cash flow.
Additionally, Cintas offers first aid and safety services, and fire protection products. This diversifies their offerings within the broader business services sector, which is characterized by a wide range of outsourced functions for businesses.
The company distributes its products and services through a network of local delivery routes and representatives, serving both small businesses and major corporations. Further research on ValueRay can provide detailed financial metrics and competitive analysis for CTAS.
Headlines to watch out for
- Uniform rental demand reflects economic health
- Facility services growth expands recurring revenue
- First Aid and Safety segment diversifies income
- Labor costs impact service profitability
- Regulatory compliance drives safety product sales
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.90b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -2.23 > 1.0 |
| NWC/Revenue: 13.56% < 20% (prev -0.27%; Δ 13.83% < -1%) |
| CFO/TA 0.22 > 3% & CFO 2.20b > Net Income 1.90b |
| Net Debt (3.04b) to EBITDA (2.86b): 1.06 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (406.4m) vs 12m ago -1.03% < -2% |
| Gross Margin: 50.25% > 18% (prev 0.49%; Δ 4.98k% > 0.5%) |
| Asset Turnover: 110.7% > 50% (prev 106.1%; Δ 4.59% > 0%) |
| Interest Coverage Ratio: 18.14 > 6 (EBITDA TTM 2.86b / Interest Expense TTM 101.1m) |
Altman Z'' 9.02
| A: 0.14 (Total Current Assets 3.54b - Total Current Liabilities 2.08b) / Total Assets 10.13b |
| B: 1.23 (Retained Earnings 12.42b / Total Assets 10.13b) |
| C: 0.19 (EBIT TTM 1.83b / Avg Total Assets 9.75b) |
| D: 2.68 (Book Value of Equity 15.23b / Total Liabilities 5.68b) |
| Altman-Z'' Score: 9.02 = AAA |
Beneish M -3.17
| DSRI: 0.99 (Receivables 1.48b/1.38b, Revenue 10.79b/9.94b) |
| GMI: 0.97 (GM 50.25% / 48.79%) |
| AQI: 0.76 (AQ_t 0.46 / AQ_t-1 0.60) |
| SGI: 1.09 (Revenue 10.79b / 9.94b) |
| TATA: -0.03 (NI 1.90b - CFO 2.20b) / TA 10.13b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of CTAS shares?
As of March 21, 2026, the stock is trading at USD 179.34 with a total of 3,332,803 shares traded.
Over the past week, the price has changed by -7.69%, over one month by -10.34%, over three months by -6.37% and over the past year by -6.98%.
Over the past week, the price has changed by -7.69%, over one month by -10.34%, over three months by -6.37% and over the past year by -6.98%.
Is CTAS a buy, sell or hold?
Cintas has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold CTAS.
- StrongBuy: 5
- Buy: 3
- Hold: 8
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the CTAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 217.1 | 21% |
| Analysts Target Price | 217.1 | 21% |
CTAS Fundamental Data Overview March 20, 2026
P/E Trailing = 39.3571
P/E Forward = 34.4828
P/S = 6.7691
P/B = 16.6442
P/EG = 3.0222
Revenue TTM = 10.79b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 2.86b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 603.5m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = 76.11b USD (73.07b + Debt 3.24b - CCE 200.8m)
Interest Coverage Ratio = 18.14 (Ebit TTM 1.83b / Interest Expense TTM 101.1m)
EV/FCF = 42.74x (Enterprise Value 76.11b / FCF TTM 1.78b)
FCF Yield = 2.34% (FCF TTM 1.78b / Enterprise Value 76.11b)
FCF Margin = 16.50% (FCF TTM 1.78b / Revenue TTM 10.79b)
Net Margin = 17.58% (Net Income TTM 1.90b / Revenue TTM 10.79b)
Gross Margin = 50.25% ((Revenue TTM 10.79b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 50.28%)
Tobins Q-Ratio = 7.51 (Enterprise Value 76.11b / Total Assets 10.13b)
Interest Expense / Debt = 0.87% (Interest Expense 28.1m / Debt 3.24b)
Taxrate = 21.19% (133.2m / 628.5m)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.19%))
Current Ratio = 1.71 (Total Current Assets 3.54b / Total Current Liabilities 2.08b)
Debt / Equity = 0.73 (Debt 3.24b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 1.06 (Net Debt 3.04b / EBITDA 2.86b)
Debt / FCF = 1.71 (Net Debt 3.04b / FCF TTM 1.78b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.47% (Net Income 1.90b / Total Assets 10.13b)
RoE = 41.07% (Net Income TTM 1.90b / Total Stockholder Equity 4.62b)
RoCE = 26.00% (EBIT 1.83b / Capital Employed (Equity 4.62b + L.T.Debt 2.43b))
RoIC = 20.07% (NOPAT 1.44b / Invested Capital 7.20b)
WACC = 7.28% (E(73.07b)/V(76.31b) * Re(7.57%) + D(3.24b)/V(76.31b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF] Terminal Value 81.42% ; FCFF base≈1.81b ; Y1≈1.90b ; Y5≈2.20b
[DCF] Fair Price = 104.3 (EV 44.74b - Net Debt 3.04b = Equity 41.70b / Shares 399.9m; r=7.28% [WACC]; 5y FCF grow 5.10% → 2.90% )
EPS Correlation: -80.10 | EPS CAGR: -46.55% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 9.97% | SUE: 2.49 | # QB: 2
EPS current Year (2026-05-31): EPS=4.88 | Chg7d=+0.002 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+10.8% | Growth Revenue=+8.4%
EPS next Year (2027-05-31): EPS=5.39 | Chg7d=-0.005 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+10.6% | Growth Revenue=+7.3%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 7.9% - Earnings Yield 2.5%)
[Growth] Growth Spread = +1.9% (Analyst 7.3% - Implied 5.4%)
P/E Forward = 34.4828
P/S = 6.7691
P/B = 16.6442
P/EG = 3.0222
Revenue TTM = 10.79b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 2.86b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 603.5m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = 76.11b USD (73.07b + Debt 3.24b - CCE 200.8m)
Interest Coverage Ratio = 18.14 (Ebit TTM 1.83b / Interest Expense TTM 101.1m)
EV/FCF = 42.74x (Enterprise Value 76.11b / FCF TTM 1.78b)
FCF Yield = 2.34% (FCF TTM 1.78b / Enterprise Value 76.11b)
FCF Margin = 16.50% (FCF TTM 1.78b / Revenue TTM 10.79b)
Net Margin = 17.58% (Net Income TTM 1.90b / Revenue TTM 10.79b)
Gross Margin = 50.25% ((Revenue TTM 10.79b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 50.28%)
Tobins Q-Ratio = 7.51 (Enterprise Value 76.11b / Total Assets 10.13b)
Interest Expense / Debt = 0.87% (Interest Expense 28.1m / Debt 3.24b)
Taxrate = 21.19% (133.2m / 628.5m)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.19%))
Current Ratio = 1.71 (Total Current Assets 3.54b / Total Current Liabilities 2.08b)
Debt / Equity = 0.73 (Debt 3.24b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 1.06 (Net Debt 3.04b / EBITDA 2.86b)
Debt / FCF = 1.71 (Net Debt 3.04b / FCF TTM 1.78b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.47% (Net Income 1.90b / Total Assets 10.13b)
RoE = 41.07% (Net Income TTM 1.90b / Total Stockholder Equity 4.62b)
RoCE = 26.00% (EBIT 1.83b / Capital Employed (Equity 4.62b + L.T.Debt 2.43b))
RoIC = 20.07% (NOPAT 1.44b / Invested Capital 7.20b)
WACC = 7.28% (E(73.07b)/V(76.31b) * Re(7.57%) + D(3.24b)/V(76.31b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF] Terminal Value 81.42% ; FCFF base≈1.81b ; Y1≈1.90b ; Y5≈2.20b
[DCF] Fair Price = 104.3 (EV 44.74b - Net Debt 3.04b = Equity 41.70b / Shares 399.9m; r=7.28% [WACC]; 5y FCF grow 5.10% → 2.90% )
EPS Correlation: -80.10 | EPS CAGR: -46.55% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 9.97% | SUE: 2.49 | # QB: 2
EPS current Year (2026-05-31): EPS=4.88 | Chg7d=+0.002 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+10.8% | Growth Revenue=+8.4%
EPS next Year (2027-05-31): EPS=5.39 | Chg7d=-0.005 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+10.6% | Growth Revenue=+7.3%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 7.9% - Earnings Yield 2.5%)
[Growth] Growth Spread = +1.9% (Analyst 7.3% - Implied 5.4%)